Ticagrelor
Who holds supplier records for Ticagrelor? 47 organisations hold a current record for Ticagrelor: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 29 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (25), China (14), Slovenia (2), Netherlands (1) and 2 other countries (2); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ticagrelor: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ticagrelor
Reading the evidence
- 47 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 26 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Ticagrelor expires 27 Jul 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (47)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ticagrelor. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHANGZHOU PHARMACEUTICAL FACTORYChinaCEP Company GMP cert on recordActive DMF 28984, 34835 · latest filing Jul 2020
- HONOUR LAB LTDIndiaCEP Company GMP cert on recordActive DMF 28879, 41833 · latest filing Jun 2025
- MSN Organics Private LimitedIndiaCEPActive DMF 28938, 34699 · latest filing Mar 2020
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 28899 · latest filing Jan 2015
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 36701 · latest filing Jan 2022
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 28446 · latest filing Aug 2014
- Jiangxi Synergy Pharmaceutical Co., LtdChinaCEPActive DMF 31620 · latest filing Mar 2017
- LEE PHARMA LTDIndiaCEP Company GMP cert on recordActive DMF 41989 · latest filing May 2025
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 38619 · latest filing Sept 2023
- Mankind Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 36711 · latest filing Feb 2022
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 29012 · latest filing Feb 2015
- PHARMARESOURCES (KAIYUAN) CO LTDCEPActive DMF 28456, 34918 · latest filing Aug 2020
- Shenzhen Salubris Pharmaceuticals Co., Ltd.ChinaCEPActive DMF 43539 · latest filing Feb 2026
- TAPI NL BVNetherlandsCEPActive DMF 28880 · latest filing Jan 2015
- USV PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 35767 · latest filing Sept 2021
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 38965 · latest filing Feb 2024
- Zakłady Farmaceutyczne Polpharma S.A.PolandCEP Company GMP cert on recordActive DMF 28674 · latest filing Sept 2014
- Zhejiang Hisun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 28923 · latest filing Dec 2014
- Zhejiang Supor Pharmaceuticals Co., LtdChinaCEP Company GMP cert on recordActive DMF 39051 · latest filing Oct 2023
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 42667 · latest filing Oct 2025
- Biocon LimitedIndiaActive DMF 39572 · latest filing Dec 2024
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 34420 · latest filing Dec 2019
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 38658 · latest filing Jul 2023
- HEC PHARM COChina Company GMP cert on recordActive DMF 28787 · latest filing Jan 2015
- INNOVARE LABS PRIVATE LTDIndiaActive DMF 36166 · latest filing Aug 2021
- JUBILANT BIOSYS LTDIndiaActive DMF 32399 · latest filing Mar 2018
- Lek Pharmaceuticals D.D.Slovenia Company GMP cert on recordActive DMF 28915 · latest filing Feb 2015
- LINHAI TIANYU PHARMACEUTICAL CO LTDChinaActive DMF 39569 · latest filing Mar 2024
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 28812 · latest filing Dec 2014
- MOREPEN LABORATORIES LTDIndia Company GMP cert on recordActive DMF 40321 · latest filing Aug 2024
- RAKS PHARMA PVT LTDIndiaActive DMF 29065 · latest filing Feb 2015
- Shanghai Huilun Pharmaceutical Co., Ltd.ChinaActive DMF 37438 · latest filing Jun 2023
- SHAOXING JINGXIN PHARMACEUTICALS CO LTDChinaActive DMF 39626 · latest filing Mar 2024
- Sichuan Qingmu Pharmaceutical Co., Ltd.ChinaActive DMF 34210 · latest filing Nov 2019
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 31482 · latest filing Mar 2018
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 33563 · latest filing Mar 2019
- WUHAN ZY PHARMACEUTICAL CO LTDActive DMF 29568 · latest filing Jul 2015
- IndiaCEP Company GMP cert on record
- IndiaCEP
- IndiaCEP Company GMP cert on record
- Shaoxing Jingxin Pharmaceutical Co., Ltd.ChinaCEP
- IndiaCEP Company GMP cert on record
- Suzhou Lixin Pharmaceutical Co., Ltd.ChinaCEP
- Zhejiang Ausun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
- ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO LTDCEP Company GMP cert on record
- ChinaCEP
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (29)
Certificates of Suitability on the EDQM register for Ticagrelor, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 34 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing | CN | CEP 2023-374 - Rev 01 Ticagrelor | Oct 2026 | Inspected Oct 2024 Belgium |
| TAPI NL B.V. Amsterdam | NL | CEP 2021-225 - Rev 02 Ticagrelor | Sept 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2021-408 - Rev 02 Ticagrelor | Aug 2026 | — |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2022-274 - Rev 01 Ticagrelor | Jul 2026 | — |
| MSN ORGANICS PRIVATE LIMITED Bibinagar Village | IN | CEP 2021-027 - Rev 02 Ticagrelor, Form II, Micronised and Non-micronised | Jun 2026 | — |
| HONOUR LAB LIMITED Hyderabad | IN | CEP 2025-583 - Rev 00 Ticagrelor, Process-II | May 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2022-128 - Rev 02 Ticagrelor | May 2026 | — |
| ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2025-604 - Rev 00 Ticagrelor, Polymorphic Form II (Process A) | Mar 2026 | Inspected Jan 2024 Hungary |
| ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2024-020 - Rev 00 Ticagrelor | Feb 2026 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | CEP 2022-072 - Rev 01 Ticagrelor | Feb 2026 | — |
| Changzhou Pharmaceutical Factory Changzhou | CN | CEP 2021-333 - Rev 02 Ticagrelor | Dec 2025 | Inspected Apr 2025 Italy |
| ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański | PL | CEP 2020-338 - Rev 04 Ticagrelor, Standard, micronised | Nov 2025 | Inspected Jul 2026 Poland |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2023-368 - Rev 00 Ticagrelor | Oct 2025 | — |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun | CN | CEP 2021-303 - Rev 01 Ticagrelor | Sept 2025 | — |
| MANKIND PHARMA LIMITED New Delhi | IN | CEP 2022-067 - Rev 01 Ticagrelor | Jun 2025 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2023-397 - Rev 00 Ticagrelor | Apr 2025 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2022-333 - Rev 01 Ticagrelor, Form II, micronised | Jan 2025 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2021-173 - Rev 01 Ticagrelor | Dec 2024 | — |
| LEE PHARMA LIMITED Hyderabad | IN | CEP 2023-140 - Rev 00 Ticagrelor, Form II (micronised) | Nov 2024 | — |
| ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City | CN | CEP 2023-011 - Rev 00 Ticagrelor | Sept 2024 | Inspected Oct 2025 France |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | CEP 2023-071 - Rev 00 Ticagrelor | Sept 2024 | — |
| USV PRIVATE LIMITED Mumbai | IN | CEP 2023-128 - Rev 00 Ticagrelor, Micronised | Jul 2024 | — |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Shenzhen City | CN | CEP 2022-491 - Rev 00 Ticagrelor | Jun 2024 | — |
| SUZHOU LIXIN PHARMACEUTICAL CO., LTD. Suzhou | CN | CEP 2022-312 - Rev 00 Ticagrelor | May 2024 | Inspected Aug 2023 France, outside 3-year window |
| PHARMARESOURCES (KAIYUAN) COMPANY LIMITED Kaiyuan City | CN | CEP 2021-362 - Rev 00 Ticagrelor | Apr 2024 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | CEP 2022-437 - Rev 00 Ticagrelor, Micronized | Mar 2024 | Inspected Jul 2025 Slovenia |
| SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu | CN | CEP 2022-187 - Rev 01 Ticagrelor | Jan 2024 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2020-331 - Rev 00 Ticagrelor | Nov 2023 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | R0-CEP 2021-348 - Rev 00 Ticagrelor | Jul 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Ticagrelor are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 33937 · filed Oct 2019
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (38 listed products contain Ticagrelor). The latest listed patent expires 27 Jul 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Ticagrelor is an oral antiplatelet agent that belongs to the class of cyclopentyltriazolopyrimidines, used to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome or myocardial infarction. It works by reversibly inhibiting the P2Y12 receptor, preventing platelet activation and aggregation.
Chemical identity
- IUPAC name
- (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
- Canonical SMILES
- CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F
- InChIKey
- OEKWJQXRCDYSHL-FNOIDJSQSA-N
- Synonyms
- Brilinta API, ar-c126532xx, azd-6140, azd6140, brilinta, brilique, possia
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- P2Y12 Platelet Inhibitor
- Mechanism of action
- Cytochrome P450 3A4 Inhibitors; P-Glycoprotein Inhibitors; P2Y12 Receptor Antagonists
- Physiologic effect
- Decreased Platelet Aggregation
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ticagrelor?
47 organisations hold an active US FDA Type II Drug Master File or a CEP for Ticagrelor: CHANGZHOU PHARMACEUTICAL FACTORY (China), HONOUR LAB LTD (India), MSN Organics Private Limited (India), Alembic Pharmaceuticals Limited (India), Divis Laboratories (India), Dr. Reddy's Laboratories Ltd. (India), Jiangxi Synergy Pharmaceutical Co., Ltd (China) and LEE PHARMA LTD (India), and 39 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ticagrelor Drug Master Files are active?
CHANGZHOU PHARMACEUTICAL FACTORY (DMF 28984, 34835), HONOUR LAB LTD (DMF 28879, 41833), MSN Organics Private Limited (DMF 28938, 34699), Alembic Pharmaceuticals Limited (DMF 28899), Divis Laboratories (DMF 36701), Dr. Reddy's Laboratories Ltd. (DMF 28446), Jiangxi Synergy Pharmaceutical Co., Ltd (DMF 31620) and LEE PHARMA LTD (DMF 41989) and 29 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ticagrelor records mean?
1 organisation has only inactive Type II DMFs for Ticagrelor. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ticagrelor have a European Certificate of Suitability?
Yes. 29 organisations hold a valid CEP for Ticagrelor on the EDQM register, including ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing (CN), TAPI NL B.V. Amsterdam (NL), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), MSN ORGANICS PRIVATE LIMITED Bibinagar Village (IN) and HONOUR LAB LIMITED Hyderabad (IN) and 23 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Ticagrelor?
Yes. The latest patent listed for an approved US product containing Ticagrelor expires 27 Jul 2036, across 38 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Ticagrelor supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ticagrelor?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.